You are here: Industry Insights > Vaccine

News List

EU to procure over 200 million doses of Pfizer-BioNTech’s Comirnaty Pharmaceutical-Technology
December 22, 2021
Pfizer and BioNTech have signed an agreement under which the European Commission (EC) and its member states will procure over 200 million additional doses of the companies’ Covid-19 vaccine Comirnaty.
WellCare of North Carolina Announces "Count on Me" COVID-19 Vaccine Incentive Campaign prnewswire
December 21, 2021
As the holidays near, along with the first detection of the omicron variant in North Carolina, WellCare of North Carolina is launching a COVID-19 vaccine member incentive program to encourage its Medicaid members to get vaccinated.
Novavax and SII obtain WHO Emergency Use Listing for Covid-19 vaccine Pharmaceutical-Technology
December 21, 2021
Novavax and its partner Serum Institute of India (SII) have obtained Emergency Use Listing (EUL) from the World Health Organization (WHO) for the former’s recombinant nanoparticle protein-based Covid-19 vaccine with Matrix-M adjuvant, NVX-CoV2373.
Japan's MHLW Approves Booster Shot for SPIKEVAX®, Moderna's mRNA COVID-19 Vaccine prnasia
December 20, 2021
Brand Institute is proud to announce its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SPIKEVAX®.
Flu Vaccine May Not Protect Against Main Flu Strain Drugs
December 20, 2021
This season's flu vaccine may do little to prevent infection with the main circulating virus strain because the strain has changed since the vaccine was developed, a new study suggests.
Pfizer Vaccine Disappoints in Kids Ages 2 to 5 Drugs
December 20, 2021
Two doses of a pediatric Pfizer-BioNTech COVID-19 vaccine failed to spur an adequate immune response in children aged 2 to 5, the companies announced Friday.
U.S. Army COVID-19 Vaccination Rate Nears 98% Drugs
December 17, 2021
Nearly 98% of the U.S. Army's active duty force had received at least one coronavirus vaccine dose as of Wednesday's deadline for mandatory vaccination, officials said Thursday.
EMA CHMP recommends J&J’s Covid-19 booster for adults Pharmaceutical-Technology
December 17, 2021
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has provided a positive opinion on the usage of Johnson & Johnson’s (J&J) Covid-19 vaccine as a booster shot for adults aged 18 years and above.
EC grants approval to Merck’s pneumonia vaccine for use in adults Pharmaceutical-Technology
December 17, 2021
The European Commission (EC) has granted approval to Merck’s (MSD) pneumococcal 15-valent conjugate vaccine, Vaxneuvance, for active immunisation to prevent invasive disease and pneumonia in adults aged 18 years and above.
Merck KGaA to design manufacturing process for first Nigerian vaccine plant through Innovative Biotech partnership CPhIonline
December 16, 2021
Merck will design the manufacturing process to help accelerate self-sufficient vaccine development and manufacturing in West Africa.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page